摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-Aib-Aib-OMe | 78375-45-8

中文名称
——
中文别名
——
英文名称
Boc-Aib-Aib-OMe
英文别名
methyl 2-methyl-2-[[2-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]propanoate
Boc-Aib-Aib-OMe化学式
CAS
78375-45-8
化学式
C14H26N2O5
mdl
MFCD24392136
分子量
302.371
InChiKey
VYDUMGJTJHWTQL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    88-89 °C
  • 沸点:
    429.3±25.0 °C(Predicted)
  • 密度:
    1.074±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.785
  • 拓扑面积:
    93.7
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:24da4df431a7b41a8a85b815fddd5849
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Boc-Aib-Aib-OMe4-二甲氨基吡啶 、 lithium hydroxide 、 正丁基锂N,N'-二环己基碳二亚胺 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 7.0h, 生成 tert-butyl N-[1-[[1-[[1-[(2R,3S,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]-2-oxopyrimidin-4-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]carbamate
    参考文献:
    名称:
    Synthesis of chemoreversible prodrugs of ara-C with variable time-release profiles. Biological evaluation of their apoptotic activity
    摘要:
    N-4-Dipeptidyl slow-release forms of the anticancer drug ara-C were prepared by acylation of the lithiated nucleotide with 4,4-dialkyloxazolinones. An azapeptide prodrug of am-C was obtained by condensation of an amino acid hydrazide with an activated nucleotide urea. The use of unnatural amino acid residues at N-4 prevented nonspecific proteolytic cleavage in biological medium. Aln-C prodrugs 10, 15, 17, and 19 released active drug with half-lives from a few minutes to several days, respectively. Activation via intramolecular N-4-deacylation did not require enzymatic intervention but was strictly dependent on the structure of the peptide chain. The prodrugs 10, 15, and 17 produced similar growth inhibition as ara-C in cultured murine leukemia cells while the azapeptide prodrug 19 was less potent reflecting the slow release of active drug with this compound. All four prodrugs retained the ability to induce apoptosis in human HL-60 leukemia cells with kinetics dictated by the rate of intramolecular N-4-deacylation. This the first demonstration for the control of apoptotic cell death by the modulation of drug release from prodrugs. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/0968-0896(96)00153-8
  • 作为产物:
    描述:
    氟甲酸叔丁酯sodium hydroxide 、 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 1,4-二氧六环乙二醇二甲醚二氯甲烷 为溶剂, 反应 16.0h, 生成 Boc-Aib-Aib-OMe
    参考文献:
    名称:
    PyBOP® and PyBroP: Two reagents for the difficult coupling of the α,α-dialkyl amino acid, Aib.
    摘要:
    The difficult coupling of alpha-aminoisobutyric acid (Aib) was carried out using PyBOP(R) and PyBroP in a comparative study with BOP and BroP. These reagents gave good results under simple conditions (one pot, r.t., 1 h). Coded amino acids could be coupled with Aib using PyBOP under standard conditions of peptide synthesis without racemization whereas the coupling of two Aib residues required PyBroP/DMAP. A fragment containing an Aib C-terminal could be coupled without epimerization of the penultimate residue.
    DOI:
    10.1016/s0040-4020(01)80922-4
点击查看最新优质反应信息

文献信息

  • Efficient coupling of α,α-dimethyl amino acid using a new chloro imidazolidium reagent, CIP
    作者:Kenichi Akaji、Naohiro Kuriyama、Yoshiaki Kiso
    DOI:10.1016/s0040-4039(00)76895-x
    日期:1994.5
    CIP (2-chloro- 1,3-dimethylimidazolidium hexafluorophosphate) was an efficient coupling agent for Nα-protected a-aminoisobutyric acid (Aib) in the presence of an additive. The reactivity was enhanced markedly by a catalytic amount of additive in the order of HOAt∼HODhbt > DMAP> HOBt. These couplings occurred without detectable racemization.
    CIP(2-氯-1,3- dimethylimidazolidium六氟磷酸盐)是一种有效的偶联剂对于N α -保护的一个在添加剂的存在下氨基异丁酸(Aib)。催化剂量按HOAt〜HODhbt> DMAP> HOBt的顺序显着提高了反应性。这些偶联发生时没有可检测的消旋作用。
  • Stapling of a 3<sub>10</sub>-Helix with Click Chemistry
    作者:Øyvind Jacobsen、Hiroaki Maekawa、Nien-Hui Ge、Carl Henrik Görbitz、Pål Rongved、Ole Petter Ottersen、Mahmood Amiry-Moghaddam、Jo Klaveness
    DOI:10.1021/jo101670a
    日期:2011.3.4
    short peptides that has shown promise when applied to 310- and α-helical peptides. However, atomic resolution structural information on the effect of side chain-to-side chain cyclization in 310-helical peptides is scarce, and reported data suggest that there is significant potential for improvement of existing methodologies. Here, we report a novel stapling methodology for 310-helical peptides using
    短肽在药物发现和化学生物学中作为先导化合物和分子探针很重要,但是它们众所周知的缺点(例如高构象柔韧性,蛋白酶不稳定性,生物利用度差和体内半衰期短)阻碍了它们的潜力被充分利用。实现。侧链对侧链的环化,例如通过闭合烯烃复分解(称为钉合),是增加短肽的生物活性的一种方法,当应用于3 10和α-螺旋肽时,该方法已显示出希望。然而,关于原子分辨率结构信息,有关侧链对侧链环化在3 10中的作用-螺旋肽是稀缺的,报道的数据表明,改进现有方法学的潜力很大。在这里,我们报告了一种新型的吻合方法,用于在模型氨基异丁酸(Aib)丰富的肽中使用铜(I)催化的叠氮化物-炔烃环加成(CuAAC)反应的3个10螺旋肽,并研究了侧链至NMR,X射线衍射,线性IR和飞秒2D IR光谱分析侧链环化。我们的数据表明,所得环肽比其无环前体和迄今报道的其他钉合3 10-螺旋肽代表更理想的3 10-螺旋。当应用于3 10时,由CuA
  • Peptides
    申请人:Jacobsen Øyvind
    公开号:US09227995B2
    公开(公告)日:2016-01-05
    A peptide which can adopt a 310-helical conformation in which the side chains of two amino acid residues in the peptide backbone are linked by a group comprising an aromatic 5-membered ring.
    一种肽,可以在其中两个氨基酸残基的侧链由包含芳香5元环的基团连接的310螺旋构象。
  • Homochiral and heterochiral associations observed in crystals of ArSO<sub>2</sub>-(Aib)<sub>5</sub>-OMe
    作者:Hidemasa Hikawa、Ayaka Takahashi、Shoko Kikkawa、Ayaka Suzuki、Yoshiki Takahashi、Naruka Sato、Misaki Okayasu、Isao Azumaya
    DOI:10.1039/d0ce01267j
    日期:——
    The molecular conformations, packing structures and intermolecular interactions of homopentapeptides from achiral α-aminoisobutyric acid (Aib), ArSO2-(Aib)5-OMe (Ar = p-tolyl, p-bromophenyl and p-methoxyphenyl), have been investigated by single-crystal X-ray diffraction analysis. The peptides were folded in 310-helical conformations consisting of two or three consecutive ten-atom intramolecular hydrogen-bonded
    通过非手性α-氨基异丁酸(Aib),ArSO 2-(Aib)5 -OMe(Ar =对甲苯基,对溴苯基和对甲氧基苯基)的同五肽的分子构象,堆积结构和分子间相互作用单晶X射线衍射分析。将肽折叠成3个10螺旋构象,该构象由两个或三个连续的III型或III'型十原子分子内氢键合的β-转角组成。在打包模式下,左手(M)和右手(P)3 10-螺旋分子形成具有头尾型分子间氢键的线性网络结构。根据功能基团或取代基的不同,获得了两种由同手性序列(⋯ M ⋯ M ⋯ M ⋯或⋯ P ⋯ P ⋯ P ⋯)和杂手性序列(⋯ M ⋯ P ⋯ M ⋯ P consisting)组成的网络结构。肽。有趣的是,当使用不同的结晶介质时,具有对甲苯基的肽1a结晶不同。
  • Chain length effects on helix-hairpin distribution in short peptides with Aib-DAla and Aib-Aib Segments
    作者:Appavu Rajagopal、Subrayashastry Aravinda、Srinivasarao Raghothama、Narayanaswamy Shamala、Padmanabhan Balaram
    DOI:10.1002/bip.21613
    日期:——
    Boc‐Val‐Aib‐DAla‐Leu‐NHMe (3) adopts a novel α‐turn conformation, stabilized by three intramolecular hydrogen bonds (two 4→1 and one 5→1). The Aib‐DAla segment adopts a type‐I′ β‐turn conformation. The observation of an NOE between Val (1) NH↔HNCH3 (5) in CD3OH suggests, that the solid state conformation is maintained in methanol solutions. © 2011 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 96: 744–756
    Aib- D Ala二肽片段倾向于形成I'/ III'型和I / III型β-转角。素数匝的出现促进了β-发夹构象的形成,而I / III型匝可以使螺旋形成成核。八肽Boc-Leu-Phe-Val-Aib- D Ala-Leu-Phe-Val-OMe(1)先前已显示在结晶状态和溶液中形成β-发夹。使用该模型肽的Boc-PHE-VAL-AIB-XXX-LEU-PHE-NHMe(已经被检查序列截短的影响2,6),将Boc-VAL-AIB-XXX-LEU-NHMe(3,7),和Boc-AIB-XXX-NHMe(4,8),其中Xxx = d喂喂 对于具有中央Aib‐Aib节段的肽,Boc‐Phe‐Val‐Aib‐Aib‐Leu‐Phe‐NHMe(6),Boc‐Val‐Aib‐Aib‐Leu‐NHMe(7)和Boc‐Aib‐Aib‐Ben NHMe(8)螺旋构象已通过NMR研究在氢键(CD 3 OH)和非氢键(CDCl
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物